PURPOSE/ OBJECTIVES: To determine the levels of pain intensity and pain interference in patients with multiple myeloma, the relationship between pain and mood disturbance, and factors that influence quality of life (QOL). DESIGN: Descriptive correlational mailed survey. SETTING: A private tertiary institution in the Midwest. SAMPLE: Convenience sample of 346 adult patients with multiple myeloma identified through an institutional database, 206 of whom responded to the surveys. METHODS: Mailed, self-administered questionnaires: Brief Pain Inventory Short Form, Profile of Mood States, QOL Scale (Cancer Patient Version), and a demographic tool. Treatment details were obtained from the database on subjects consenting to participate. MAIN RESEARCH VARIABLES: Pain intensity, pain interference, psychologic functioning, and QOL. FINDINGS: 29% (n = 60) of subjects reported moderate to severe pain intensity. Significant associations were found between pain intensity and mood disturbance scores. As pain interference increased, so did levels of mood disturbance. A joint predictive model explained 74.6% of the variability in total QOL scores. CONCLUSIONS: Cancer pain remains undertreated, and patients with myeloma are no exception. Pain and mood disturbance scores were significant predictors of QOL in this group of patients. Subjects with multiple myeloma reported higher levels of mood disturbance than patients with cancer from other studies. IMPLICATIONS FOR NURSING PRACTICE: The oncology nurse is in a key position to facilitate ongoing, adequate pain and psychosocial assessment of patients with myeloma. Further study is needed to determine if control of pain and mood disturbance factors has a positive effect on the various domains of QOL.
PURPOSE/ OBJECTIVES: To determine the levels of pain intensity and pain interference in patients with multiple myeloma, the relationship between pain and mood disturbance, and factors that influence quality of life (QOL). DESIGN: Descriptive correlational mailed survey. SETTING: A private tertiary institution in the Midwest. SAMPLE: Convenience sample of 346 adult patients with multiple myeloma identified through an institutional database, 206 of whom responded to the surveys. METHODS: Mailed, self-administered questionnaires: Brief Pain Inventory Short Form, Profile of Mood States, QOL Scale (CancerPatient Version), and a demographic tool. Treatment details were obtained from the database on subjects consenting to participate. MAIN RESEARCH VARIABLES: Pain intensity, pain interference, psychologic functioning, and QOL. FINDINGS: 29% (n = 60) of subjects reported moderate to severe pain intensity. Significant associations were found between pain intensity and mood disturbance scores. As pain interference increased, so did levels of mood disturbance. A joint predictive model explained 74.6% of the variability in total QOL scores. CONCLUSIONS:Cancer pain remains undertreated, and patients with myeloma are no exception. Pain and mood disturbance scores were significant predictors of QOL in this group of patients. Subjects with multiple myeloma reported higher levels of mood disturbance than patients with cancer from other studies. IMPLICATIONS FOR NURSING PRACTICE: The oncology nurse is in a key position to facilitate ongoing, adequate pain and psychosocial assessment of patients with myeloma. Further study is needed to determine if control of pain and mood disturbance factors has a positive effect on the various domains of QOL.
Authors: Pasquale Niscola; Agostina Siniscalchi; Andrea Tendas; Paolo de Fabritiis; Tommaso Caravita; Fabio Efficace Journal: Support Care Cancer Date: 2015-08-04 Impact factor: 3.603
Authors: Masahiro Hiasa; Tatsuo Okui; Yohance M Allette; Matthew S Ripsch; Ge-Hong Sun-Wada; Hiroki Wakabayashi; G David Roodman; Fletcher A White; Toshiyuki Yoneda Journal: Cancer Res Date: 2017-03-02 Impact factor: 12.701
Authors: Elizabeth Ann Coleman; Julia A Goodwin; Sharon K Coon; Kathy Richards; Carol Enderlin; Robert Kennedy; Carol B Stewart; Paula McNatt; Kim Lockhart; Elias J Anaissie; Bart Barlogie Journal: Cancer Nurs Date: 2011 May-Jun Impact factor: 2.592
Authors: Michel Delforge; Leonard Minuk; Jean-Claude Eisenmann; Bertrand Arnulf; Letizia Canepa; Alberto Fragasso; Serge Leyvraz; Christian Langer; Yousef Ezaydi; Dan T Vogl; Pilar Giraldo-Castellano; Sung-Soo Yoon; Charles Zarnitsky; Martine Escoffre-Barbe; Bernard Lemieux; Kevin Song; Nizar Jacques Bahlis; Shien Guo; Mara Silva Monzini; Annette Ervin-Haynes; Vanessa Houck; Thierry Facon Journal: Haematologica Date: 2015-03-13 Impact factor: 9.941
Authors: Madeline L O'Sullivan; Rebecca A Shelby; Caroline S Dorfman; Sarah A Kelleher; Hannah M Fisher; Krista A Rowe Nichols; Francis J Keefe; Anthony D Sung; Tamara J Somers Journal: Support Care Cancer Date: 2017-11-09 Impact factor: 3.359
Authors: Karin Jordan; Irina Proskorovsky; Philip Lewis; Jack Ishak; Krista Payne; Noreen Lordan; Charalampia Kyriakou; Cathy D Williams; Sarah Peters; Faith E Davies Journal: Support Care Cancer Date: 2014-02 Impact factor: 3.603
Authors: Lara Groeneveldt; Gill Mein; Rachel Garrod; Andrew P Jewell; Ken Van Someren; Richard Stephens; Shirley P D'Sa; Kwee L Yong Journal: BMC Cancer Date: 2013-01-24 Impact factor: 4.430